Abstract
In most countries the proportion of gross national product devoted to health care increased during the 1960s and 70s, itself a period of economic growth (Maxwell, 1981). However, the current concern is with improving the efficiency of, or value for money from, health care delivery systems. This concern manifests itself in different ways, depending on the way health care is organized and financed in a given country. In those countries with a ‘liberal’ (decentralized, market-based) system, such as the USA or the Federal Republic of Germany, the concern may be with rising costs. In those with a ‘socialized’ system, such as the United Kingdom or Sweden, the concern may be with meeting health ‘needs’ in the face of an increasingly stretched health service budget.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bally Y D. Clinical budgeting in the NHS: or going Dutch (Swedish, French). Discussion paper 05/82. Aberdeen, Health Economics Research Unit 1982.
Boyle M H, Torrance G W, Sinclair J C and Horwood S P. Economic evaluation of neonatal intensive care of very-low-birthweight infants. N Engl J Med, 1983; 305: 1330–7.
Churchill D N, Morgan J and Torrance G W. Quality of life in end-stage renal disease. Periton Dialys Bull, 1984; 4: 20–3.
Churchill D N, Lemon B C and Torrance G W. Cost-effectiveness analysis comparing continuous ambulatory peritoneal dialysis to hospital hemodialysis. Med Decision Making, 1984; 4: 489–500.
Culyer A J and Maynard A K. Cost-effectiveness of duodenal ulcer treatment. Soc Sci Med, 1981; 15c: 3–11.
Department of Clinical Epidemiology and Biostatics, McMaster University Health Science Center. How to read clinical journals VII: To understand an economic evaluation (parts A and B). Can Med Assoc J, 1984; 130:1428–34 and 1542–49.
Drummond M F. Principles of Economic Appraisal in Health Care. Oxford, Oxford Medical Publications 1980.
Drummond M F. Studies in Economic Appraisal in Health Care. Oxford, Oxford Medical Publications 1981.
Drummond M F, Ludbrook A, Lowson K V and Steel A. Studies in Economic Appraisal in Health Care: Volume Two. Oxford, Oxford Medical Publications 1986.
Drummond M F and Stoddart G L. Economic analysis and clinical trials. Controlled Clin Trials, 1984; 5:115–28.
Drummond M F, Stoddart G L and Torrance G W. Methods for the Economic Evaluation of Health Care Programmes. Oxford, Oxford Medical Publications 1986.
Drummond M F and Ward G H. The financial burden of stroke and the economic evaluation of treatment alternatives. In Clifford Rose, F (ed). Proceedings of the 3rd International Stroke Symposium. London, Royal Society of Medicine 1986
Evans R G and Robinson G C. Surgical day care: Measurements of the economic payoff. Can Med Assoc J, 1980; 123: 873–30.
Foster G E, Bourke J B, Bolwell J, Doran J, Balfour T W, Holliday A, Harcastle J D and Marshall D J. Clinical and economic consequences of wound sepsis after appendicectomy and their modification by metronidazole or providone iodine. Lancet, 1981; i: 769–71.
Hull R D, Hirsh J, Sackett D L and Stoddart G L. Cost effectiveness of clinical diagnosis, venography and non-invasive testing in patients with symptomatic deep-vein thrombosis. N Engl J Med, 1981; 304:1561–7.
Hull R D, Hirsh J, Sackett D L and Stoddart G L. Cost effectiveness of primary and secondary prevention of fatal pulmonary embolism in high-risk surgical patients. Can Med Assoc J, 1982; 127: 990–5.
Lowson K V, Drummond M F and Bishop J. Costing new services: long-term oxygen therapy for chronic bronchitics. Lancet, 1981; i: 1146–9.
Ludbrook A. A cost effectiveness analysis of the treatment of chronic renal failure. Appl Econ, 1981; 13: 337–50.
Mattson W, Gynning I, Carlsson B, Mauritzon S-E. Cancer chemotherapy in advanced malignant disease: a cost benefit analysis. Acta Radiol (Oncol), 1979; 18:509–20.
Maxwell R J. Health and Wealth: an International Study of Health Care Spending. Lexington Books for Sandoz Institute for Health and Socio-economic studies 1981.
Neutra R. Indications for the surgical treatment of suspected acute appendicitis: a cost effectiveness approach. In Bunker J P, Barnes B A and Mosteller F, eds. Costs, Risk and Benefits of Surgery. New York, Oxford University Press, 1977.
Paterson M. Measuring the socio-economic benefits of auranofin. In Teeling Smith G, (ed). Measuring the Social Benefits of Medicines. London, Office of Health Economics 1983
Ricardo-Campbell R. Preliminary methodology for controlled cost-benefit study of drug impact: the effect of Cimetidine on days of work lost in a short-term trial in duodenal ulcer. J Clin Gatroenterol, 1980; 2: 37–41.
Shapiro M, Schoenbaum S C, Tager IB, Munoz A and Polk F. Benefit-cost analysis of antimicrobial prophylaxis in abdominal and vaginal hysterectomy. J Am Med Assoc, 1983; 249:1290–4.
Teeling Smith G. Measurement of Health. London, Office of Health Economics 1985.
Thompson M S, Read J L and Laing M. Feasibility of willingness-to-pay measurement in chronic arthritis. Med Decis Making, 1984; 4:195–215.
Warner K E and Hutton R C. Cost-benefit and cost-effectiveness analysis health care: growth and composition of the literature. Med Care 1980; 18:1069–84.
Warner K E and Luce B R. Cost-Benefit and Cost-Effectiveness in Health Care: Principles, Practice and Potential.M Ann Arbor, Health Administration Press 1982.
Weisbrod B A, Test M A and Stein L I. Alternative to mental hospital treatment II Economic benefit-cost analysis. Arch Gen Psychiat, 1980; 37: 400–5.
Williams A H. Economics of coronary artery bypass grafting. Br Med J, 1985; 291: 326–9.
Wickings H I and Coles J. The ethical imperative of clinical budgeting. Nuffield/York Portfolios No 10. London, Nuffield Provincial Hospitals Trust 1985.
World Health Organization (Regional Office for Europe). Guidelines for health care practice in relation to cost-effectiveness. Euro Reports and Studies 53. Copenhagen, WHO 1981.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers
About this chapter
Cite this chapter
Drummond, M.F. (1988). The Assessment of Drug Therapy in Social and Economic Terms. In: Walker, B.C., Walker, S.R. (eds) Trends and Changes in Drug Research and Development. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2659-2_5
Download citation
DOI: https://doi.org/10.1007/978-94-009-2659-2_5
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-85200-839-3
Online ISBN: 978-94-009-2659-2
eBook Packages: Springer Book Archive